Product Program year 2024 Source: CMS Open Payments

Trima Accel

Device Apheresis

PDI 05020583810020

Open in the dashboard

General payments

$255,930

92 payments

Research payments

$6,955

1 payment

Through program year 2024, $255,930 in general payments and $6,955 in research payments were reported against Trima Accel (Apheresis).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

5 rows
Year Kind Amount Payments
2024 General $65,164 20
2023 General $59,422 25
2023 Research $6,955 1
2022 General $55,897 29
2021 General $75,447 18

Breakdown

Who paid General payments · program years 2021–2024
  1. Terumo BCT, Inc. $255,930 92 payments
Top recipients General payments · program year 2024
  1. Ira Davis Pediatric Nephrology · Cleveland, OH $53,500 82% · 10 payments
  2. Miguel Abboud Pediatric Hematology-Oncology · Charleston, SC $5,530 8% · 1 payment
  3. Charles Knudson Blood Banking & Transfusion Medicine · Iowa City, IA $4,510 7% · 1 payment
  4. John Manis Hematology & Oncology · Boston, MA $1,200 2% · 1 payment
  5. Barbara Bryant Blood Banking & Transfusion Medicine · Milwaukee, WI $150 <1% · 1 payment

The top 5 of 11 recipients; each share is of general payments naming this product in 2024.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2024
  1. Pediatric Nephrology Pediatrics $53,500 82% · 1 practitioner
  2. Pediatric Hematology-Oncology Pediatrics $5,568 9% · 2 practitioners
  3. Blood Banking & Transfusion Medicine Pathology $4,719 7% · 3 practitioners
  4. Hematology & Oncology Internal Medicine $1,200 2% · 1 practitioner
  5. Anatomic Pathology & Clinical Pathology Pathology $177 <1% · 4 practitioners

Each share is of general payments naming this product to practitioners with a specialty in 2024. Each practitioner is counted under their primary specialty.

Where the money went General payments · program year 2024
  1. Ohio $53,518 82% · 2 recipients
  2. South Carolina $5,530 8% · 1 recipient
  3. Iowa $4,510 7% · 1 recipient
  4. Massachusetts $1,220 2% · 2 recipients
  5. Wisconsin $150 <1% · 1 recipient

The top 5 of 8 states; each share is of general payments naming this product in 2024 where a state was reported.

The top 25 states, free in the app

92 general · 1 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2024

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record